Diabetic peripheral neuropathy is a significant source of morbidity and mortality and is implicated in approximately 50% to 75% of nontraumatic amputations. 4 It has been defined as “the ...

Diabetic Peripheral Neuropathy Pipeline Report helps in identifying emerging players in the market and their portfolios. The global Diabetic Peripheral Neuropathy therapeutic landscape evaluates ...

Assessment for DSPN, the document advises, should be undertaken at diagnosis of type 2 diabetes, 5 years after diagnosis of type 1 diabetes, in those with prediabetes and symptoms of peripheral ...

Pilot study finds 1 in 4 young people with type 2 diabetes have peripheral neuropathy, a rate approaching that seen in adults with the condition.

The assessment is fast, noninvasive, and highly specific. The results are corrected for the effect of age. In this issue of Polish Archives of Internal Medicine (Pol Arch Intern Med), Sertbas et al 10 ...

One of the devices’ manufacturers, Massachusetts-based NeuroMetrix, said the finding reveals the importance of testing as early as possible for diabetic peripheral neuropathy (DPN), as it gives ...

Adults with type 1 diabetes for 50 years or more are less likely to have distal symmetric polyneuropathy if they performed at least 150 minutes of physical activity weekly, according to study data.

High Frequency Spinal Stimulation Succeeds in Diabetic Neuropathy — Pain relief was significant and durable in SENZA-PDN trial by Kristen Monaco , Staff Writer, MedPage Today May 29, 2021 ...

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Diabetic Neuropathic Pain pipeline constitutes 10+ key companies continuously working towards developing 12 ...